Office Address
14, Residency Road, Udaipur, Rajasthan 313001
Office Address
14, Residency Road, Udaipur, Rajasthan 313001


GURUGRAM / MUMBAI — North and East India’s leading tertiary healthcare chain Paras Healthcare Limited is launching its ₹1,450 crore Initial Public Offering (IPO) on Wednesday, October 21, 2026. The company has fixed its price band at ₹660 to ₹693 per equity share with a lot size of 21 shares. As of October 20, 2026, live primary market trackers report the Grey Market Premium (GMP) at ₹77 per share, indicating expected listing gains of 11.11% with an estimated debut price of ₹770.
Paras Healthcare operates over 2,100 operational beds across 8 multi-specialty tertiary care hospitals in underserved North and East Indian cities including Gurugram, Patna, Panchkula, Udaipur, Ranchi, Srinagar, and Kanpur. Below is the comprehensive issue structure filed with SEBI:
| Parameter | Details & Specification |
|---|---|
| IPO Open Date | Wednesday, October 21, 2026 |
| IPO Close Date | Friday, October 23, 2026 |
| Tentative Allotment Date | Monday, October 26, 2026 |
| Initiation of Refunds / Unblocking | Tuesday, October 27, 2026 |
| Credit of Shares to Demat | Tuesday, October 27, 2026 |
| Listing Date (BSE & NSE) | Wednesday, October 28, 2026 |
| Face Value | ₹1.00 per equity share |
| Price Band | ₹660.00 to ₹693.00 per equity share |
| Minimum Lot Size | 21 Shares (₹14,553 at Upper Band) |
| Total Issue Size | 2,09,23,520 Shares (₹1,450.00 Crore) |
| Fresh Issue Component | 72,15,007 Shares (₹500.00 Crore) |
| Offer for Sale (OFS) | 1,37,08,513 Shares (₹950.00 Crore) |
| Post-Issue Market Capitalization | ₹7,498.34 Crore (at ₹693 Upper Cap) |
| Registrar | MUFG Intime India Private Limited (formerly Link Intime) |
| Lead Managers | ICICI Securities Limited, IIFL Securities Limited |
The Grey Market Premium reflects unofficial secondary trading demand from primary market dealers ahead of the official exchange listing. The date-wise tracker below syncs live quotes and intraday shifts directly from InvestorGain:
Daily grey market premium quotes, intraday movements, and expected profit per lot
| GMP Date | Issue Price | Grey Market Premium (GMP) | Est. Listing Price | Expected Gain (%) | Est. Profit / Lot | Trend |
|---|---|---|---|---|---|---|
| 20-Oct 23:37 LATEST | ₹693 | ₹50 | ₹743 | 7.22% | ₹1,050 | Volatile |
| 19-Oct 23:37 | ₹693 | ₹78 | ₹771 | 11.26% | ₹1,638 | Stable |
| 18-Oct 23:37 | ₹693 | ₹92 | ₹785 | 13.28% | ₹1,932 | Stable |
| 17-Oct 23:37 | ₹693 | ₹96 | ₹789 | 13.85% | ₹2,016 | Stable |
| 16-Oct 23:37 | ₹693 | ₹95 | ₹788 | 13.71% | ₹1,995 | Stable |
| 15-Oct 23:37 | ₹693 | ₹95 | ₹788 | 13.71% | ₹1,995 | Stable |
| 14-Oct 23:37 | ₹693 | ₹83 | ₹83 | 0.00% | ₹0 | Initial |
⏱️ Today’s Intraday Movement Breakdown:
*Note: Grey Market Premium (GMP) is strictly indicative and reflects unofficial trading. Estimated listing gains are based on the upper price band.
Bidders can apply for a minimum of 21 shares and in multiples of 21 shares thereafter across distinct retail and HNI bidding categories:
| Investor Category | Lots | Total Shares | Application Amount (@ ₹693 Cap) |
|---|---|---|---|
| Retail Individual (Min) | 1 Lot | 21 Shares | ₹14,553 |
| Retail Individual (Max) | 13 Lots | 273 Shares | ₹1,89,189 |
| Small HNI / sNII (Min) | 14 Lots | 294 Shares | ₹2,03,742 |
| Small HNI / sNII (Max) | 68 Lots | 1,428 Shares | ₹9,89,604 |
| Big HNI / bNII (Min) | 69 Lots | 1,449 Shares | ₹10,04,157 |

Paras Healthcare has achieved a decisive operational and financial turnaround over the past two fiscal years, transitioning from expansion-phase net losses into solid profitability and strong EBITDA margins:
| Financial Parameter (₹ Crore) | Q1 FY27 (Jun 30, 2026) | FY26 (Mar 31, 2026) | FY25 (Mar 31, 2025) | FY24 (Mar 31, 2024) |
|---|---|---|---|---|
| Total Revenue | ₹478.75 | ₹1,628.78 | ₹1,314.21 | ₹1,151.02 |
| EBITDA | ₹113.48 | ₹335.58 | ₹156.46 | ₹154.41 |
| EBITDA Margin (%) | 23.70% | 20.60% | 11.90% | 13.41% |
| Profit After Tax (PAT) | ₹49.68 | ₹43.83 | -₹57.98 | -₹15.33 |
| PAT Margin (%) | 10.38% | 2.69% | -4.41% | -1.33% |
| Net Worth | ₹444.96 | ₹394.94 | ₹280.49 | ₹338.51 |
| Total Borrowings | ₹1,429.49 | ₹1,393.86 | ₹1,232.12 | ₹923.92 |
| Return on Net Worth (RoNW) | 11.83% (Ann.) | 12.98% | -18.73% | -4.52% |
In Q1 FY27, revenue reached ₹478.75 crore with PAT surging to ₹49.68 crore—surpassing the full previous fiscal year’s net earnings—reflecting higher bed occupancy and mature contributions from newer facilities in Srinagar and Kanpur.
From the ₹500 crore fresh capital component, Paras Healthcare intends to allocate proceeds toward immediate balance sheet deleveraging:
Deleveraging will save substantial annual finance costs, boosting PAT margins post-listing. Investors tracking current primary market opportunities can also follow our date-wise analyses on EAAA India Alternatives IPO details and GMP and BLS Polymers IPO live allotment updates, alongside our breakdown of the Jio Platforms IPO price band momentum.
Share allotment will be finalized tentatively by Monday, October 26, 2026. Bidders can check allotment status online using these direct steps:
Go to the BSE Investor Application Status portal, choose Issue Type as “Equity”, select “Paras Healthcare Limited”, enter Application Number and PAN, and verify allotment instantaneously.
As of October 20, 2026, the Grey Market Premium (GMP) for Paras Healthcare IPO is ₹77 per share. At the upper price band of ₹693, the estimated listing price is ₹770 per share, indicating potential listing gains of 11.11%.
The price band is fixed at ₹660 to ₹693 per equity share with a face value of ₹1 each. The minimum bid lot is 21 equity shares (₹14,553 at the cap price).
The issue opens for public subscription on Wednesday, October 21, 2026, and closes on Friday, October 23, 2026.
Paras Healthcare shares are scheduled to list on BSE and NSE on Wednesday, October 28, 2026.
Disclaimer: Grey Market Premium (GMP) is an unregulated, indicative indicator and should not be treated as investment advice. Investors should base their decisions on the Red Herring Prospectus (RHP) filed with SEBI and consult certified financial planners before bidding.
Add Udaipur Mirror as a preferred source on Google to see more of our travel guides in your AI overviews.